
Keywords: ROI; reactive oxygen intermediates; VEGF; vascular endothelial growth factor; Arg-1; Arginase-1; HO-1; Heme Oxygenase-1; SRXN1; Sulphiredoxin-1; iNOS; inducible nitric oxide synthase; Th1; T-helper cells1; IFN-γ; interferon gamma; IL-4; interleukin-4; Th